← ABBOTT LABORATORIES
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net earnings | $1.4b | $477.0m | $2.4b | $3.7b | $4.5b | $7.1b | $6.9b | $5.7b | $13.4b | $6.5b | |
| Net Income (Loss) Attributable to Parent | $1.4b | $477.0m | $2.4b | $3.7b | $4.5b | $7.1b | $6.9b | $5.7b | $13.4b | $6.5b | |
| Net Income (Loss) Available to Common Stockholders, Basic | $1.4b | $468.0m | $2.4b | $3.7b | $4.5b | $7.0b | $6.9b | $5.7b | $13.4b | $6.5b | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $1.1b | $353.0m | $2.3b | $3.7b | $4.5b | $7.1b | $6.9b | — | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $337.0m | $124.0m | $34.0m | — | $24.0m | — | $0 | — | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | $477.0m | $2.4b | $3.7b | $4.5b | $7.1b | — | — | — | — | |
| Amortization of Debt Issuance Costs and Discounts | $165.0m | $5.0m | — | — | — | — | — | — | — | — | |
| Amortization of Intangible Assets | $550.0m | $2.0b | $2.2b | $1.9b | $2.1b | $2.0b | $2.0b | $2.0b | $1.9b | $1.7b | |
| Depreciation | $803.0m | $1.0b | $1.1b | $1.1b | $1.2b | $1.5b | $1.3b | $1.3b | $1.3b | $1.4b | |
| Deferred Income Tax Expense (Benefit) | ($127.0m) | ($890.0m) | $745.0m | ($491.0m) | ($108.0m) | ($509.0m) | ($659.0m) | ($461.0m) | ($8.0b) | $441.0m | |
| Equity Method Investment, Other than Temporary Impairment | $947.0m | — | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | $55.0m | $111.0m | — | — | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | $546.0m | $640.0m | $685.0m | $644.0m | $673.0m | $664.0m | |
| Share-based Payment Arrangement, Noncash Expense | $310.0m | $406.0m | $477.0m | $519.0m | $546.0m | $640.0m | $685.0m | $644.0m | $673.0m | $664.0m | |
| Share-based compensation | $310.0m | $406.0m | $477.0m | $519.0m | $546.0m | $640.0m | $685.0m | $644.0m | $673.0m | $664.0m | |
| Gain (Loss) on Disposition of Business | — | $1.2b | — | — | — | — | — | — | — | — | |
| Gain (Loss) on Extinguishment of Debt | — | — | ($167.0m) | ($63.0m) | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $350.0m | $1.9b | $539.0m | $390.0m | $497.0m | $1.1b | $1.4b | $941.0m | ($6.4b) | $1.9b | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $559.0m | $493.0m | |
| Other Nonoperating Income (Expense) | ($945.0m) | $1.3b | $139.0m | $191.0m | $103.0m | $277.0m | $321.0m | $479.0m | $376.0m | $548.0m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($495.0m) | $34.0m | ($28.0m) | ($7.0m) | $8.0m | ($1.0m) | ($2.0m) | ($41.0m) | $27.0m | $50.0m | |
| Goodwill | $7.7b | $24.0b | $23.3b | $23.2b | $23.7b | $23.2b | $22.8b | $23.7b | $23.1b | $24.0b | |
| Income taxes | ($699.0m) | $1.1b | ($214.0m) | ($545.0m) | ($614.0m) | ($908.0m) | ($383.0m) | ($585.0m) | ($8.0b) | ($5.0m) | |
| Increase (Decrease) in Accounts Receivable | $177.0m | $207.0m | $190.0m | $275.0m | $924.0m | $383.0m | $68.0m | $356.0m | $691.0m | $652.0m | |
| Increase (Decrease) in Inventories | $98.0m | ($249.0m) | $514.0m | $593.0m | $493.0m | $456.0m | $1.4b | $232.0m | $58.0m | ($195.0m) | |
| Inventories | ($98.0m) | $249.0m | ($514.0m) | ($593.0m) | ($493.0m) | ($456.0m) | ($1.4b) | ($232.0m) | ($58.0m) | $195.0m | |
| Investing and financing losses, net | $86.0m | $47.0m | $126.0m | $184.0m | $425.0m | $55.0m | $215.0m | $126.0m | $482.0m | $65.0m | |
| Investment Income, Interest | $99.0m | $124.0m | $105.0m | $94.0m | $46.0m | $43.0m | $183.0m | $385.0m | $344.0m | $308.0m | |
| Other | $42.0m | $35.0m | $48.0m | $27.0m | ($11.0m) | $26.0m | $0 | $22.0m | $9.0m | ($82.0m) | |
| Payments of Financing Costs | $170.0m | — | — | — | — | — | — | — | — | — | |
| Prepaid expenses and other assets | $113.0m | $109.0m | $23.0m | ($138.0m) | ($627.0m) | ($312.0m) | ($75.0m) | ($542.0m) | ($796.0m) | ($1.3b) | |
| Proceeds from Stock Options Exercised | $248.0m | $350.0m | $271.0m | $298.0m | $245.0m | $255.0m | $167.0m | $167.0m | $264.0m | $396.0m | |
| Proceeds from business dispositions | $25.0m | $6.0b | $48.0m | $48.0m | $58.0m | $134.0m | $48.0m | $40.0m | $1.0m | $0 | |
| Purchases of common shares | ($522.0m) | ($117.0m) | ($238.0m) | ($718.0m) | ($403.0m) | ($2.3b) | ($3.8b) | ($1.2b) | ($1.3b) | ($893.0m) | |
| Trade accounts payable and other liabilities | ($652.0m) | $615.0m | $747.0m | $220.0m | $1.8b | $1.3b | $420.0m | ($760.0m) | $356.0m | $954.0m | |
| Trade receivables | ($177.0m) | ($207.0m) | ($190.0m) | ($275.0m) | ($924.0m) | ($383.0m) | ($68.0m) | ($356.0m) | ($691.0m) | ($652.0m) | |
| Unrealized Gain (Loss) on Investments | — | — | $50.0m | — | — | — | — | — | — | — | |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | $16.0m | — | — | — | — | — | — | — | — | — | |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | $321.0m | $124.0m | $34.0m | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $3.2b | $5.6b | $6.3b | $6.1b | $7.9b | $10.5b | $9.6b | $7.3b | $8.6b | $9.6b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.1b | $1.1b | $1.4b | $1.6b | $2.2b | $1.9b | $1.8b | $2.2b | $2.2b | $2.2b | |
| Acquisitions of businesses and technologies, net of cash acquired | ($80.0m) | ($17.2b) | ($54.0m) | ($170.0m) | ($42.0m) | ($187.0m) | $0 | ($877.0m) | $0 | ($105.0m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | $80.0m | $17.2b | $54.0m | $170.0m | $42.0m | $187.0m | $0 | $877.0m | $0 | $105.0m | |
| Payments to Acquire Investments | — | — | — | — | — | — | $185.0m | $159.0m | $169.0m | $167.0m | |
| Purchases of investment securities | ($2.8b) | ($210.0m) | ($131.0m) | ($103.0m) | ($83.0m) | ($173.0m) | ($185.0m) | ($159.0m) | ($169.0m) | ($167.0m) | |
| Proceeds from sales of investment securities | $3.7b | $129.0m | $73.0m | — | $10.0m | $77.0m | $152.0m | $43.0m | $28.0m | $3.0m | |
| Payments for (Proceeds from) Other Investing Activities | ($42.0m) | ($35.0m) | ($48.0m) | ($27.0m) | ($19.0m) | ($26.0m) | ($22.0m) | ($22.0m) | ($9.0m) | ($18.0m) | |
| Net Cash From (Used in) Investing Activities | ($248.0m) | ($9.6b) | ($1.4b) | ($1.8b) | ($2.2b) | ($2.0b) | ($1.7b) | ($3.1b) | ($2.3b) | ($2.4b) | |
| Net Cash Provided by (Used in) Investing Activities | ($248.0m) | ($9.6b) | ($1.4b) | ($1.8b) | ($2.2b) | ($2.0b) | ($1.7b) | ($3.1b) | ($2.3b) | ($2.4b) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Long-term Debt | $14.9b | $6.7b | $4.0b | $1.8b | $1.3b | $4.0m | $7.0m | $2.0m | $223.0m | $5.0m | |
| Proceeds from issuance of (repayments of) short-term debt, net and other | ($1.8b) | ($1.0b) | ($26.0m) | — | $2.0m | ($204.0m) | $47.0m | $21.0m | ($100.0m) | ($115.0m) | |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | $14.9b | $6.7b | $4.0b | $1.8b | $1.3b | $4.0m | $7.0m | $2.0m | $223.0m | $5.0m | |
| Repayments of Long-term Debt | $12.0m | $8.7b | $12.4b | $3.4b | $1.3b | $48.0m | $753.0m | $2.5b | $660.0m | $1.5b | |
| Repayments of long-term debt and debt with maturities over 3 months | ($12.0m) | ($8.7b) | ($12.4b) | ($3.4b) | ($1.3b) | ($48.0m) | ($753.0m) | ($2.5b) | ($660.0m) | ($1.5b) | |
| Payments for Repurchase of Common Stock | $522.0m | $117.0m | $238.0m | $718.0m | $403.0m | $2.3b | $3.8b | $1.2b | $1.3b | $893.0m | |
| Payments of Ordinary Dividends, Common Stock | $1.5b | $1.8b | $2.0b | $2.3b | $2.6b | $3.2b | $3.3b | $3.6b | $3.8b | $4.1b | |
| Dividends Payable, Current | $391.0m | $489.0m | $563.0m | $635.0m | $798.0m | $831.0m | $887.0m | $955.0m | $1.0b | $1.1b | |
| Dividends paid | ($2k) | ($2k) | ($2k) | ($2k) | ($3k) | ($3k) | ($3k) | ($4k) | ($4k) | ($4k) | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | ($11.0m) | — | $0 | — | — | ($82.0m) | |
| Net Cash From (Used in) Financing Activities | $11.1b | ($5.3b) | ($10.4b) | ($4.3b) | ($2.8b) | ($5.5b) | ($7.6b) | ($7.1b) | ($5.4b) | ($6.3b) | |
| Net Cash Provided by (Used in) Financing Activities | $11.1b | ($5.3b) | ($10.4b) | ($4.3b) | ($2.8b) | ($5.5b) | ($7.6b) | ($7.1b) | ($5.4b) | ($6.3b) | |
| Effect of exchange rate changes on cash and cash equivalents | ($483.0m) | $116.0m | ($116.0m) | ($16.0m) | $71.0m | ($70.0m) | ($122.0m) | ($23.0m) | ($96.0m) | $71.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($483.0m) | $116.0m | ($5.6b) | $16.0m | $3.0b | $3.0b | $83.0m | ($3.0b) | $720.0m | $906.0m | |
| Net Increase (Decrease) in Cash and Cash Equivalents | $13.6b | ($9.2b) | ($5.6b) | $16.0m | $3.0b | $3.0b | $83.0m | ($3.0b) | $720.0m | $906.0m | |
| Cash and Cash Equivalents, Beginning of Year | $5.0b | $18.6b | $3.8b | $3.9b | $6.8b | $9.8b | $9.9b | $6.9b | $7.6b | $8.5b | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $3.8b | $3.9b | $6.8b | $9.8b | $9.9b | $6.9b | $7.6b | $8.5b | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $181.0m | $917.0m | $845.0m | $677.0m | $549.0m | $544.0m | $563.0m | $662.0m | $604.0m | $545.0m | |
| Income Taxes Paid, Net | $620.0m | $570.0m | $740.0m | $930.0m | $970.0m | $1.9b | $1.9b | $1.5b | $1.7b | $1.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.